homocysteine has been researched along with fluorobenzenes in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (43.75) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cornwell, PE; Morgan, SL; Vaughn, WH | 1 |
| Crooks, R; Dudman, NP; Guo, XW; Silberberg, JS; Xie, L | 1 |
| Deufel, T; Feussner, A; Rolinski, B; Roscher, AA; Weiss, N; Wolfram, G | 1 |
| Bosoni, T; Montalbetti, L; Moratti, R; Rizzo, V; Scoglio, E; Valli, M | 1 |
| Bamforth, FJ; Cembrowski, GS; Dias, VC; Hyndman, ME; Parsons, HG; Tesanovic, M | 1 |
| Arcelloni, C; D'Angelo, A; Fermo, I; Mazzola, G; Paroni, R | 1 |
| Delport, R; Riezler, R; Ubbink, JB; Vermaak, WJ | 1 |
| Ubbink, JB | 1 |
| Fermo, I; Paroni, R | 1 |
| Chu, KM; Ding, YA; Leu, HB; Lu, TM; Sheu, WH; Yin, WH | 1 |
| Corretti, V; Ferrannini, E; Madec, S; Santini, E; Solini, A | 1 |
| Aoyagi, K; Ichinose, S; Ikeda, R; Maeda, M; Maeda, T; Nakamura, M; Nakashima, K; Nakazato, M; Ohba, Y; Takamura, N; Wada, M | 1 |
| Allemann, Y; Burow, A; Hess, OM; Klaey, M; Shaw, SG; Wustmann, K | 1 |
| Ahn, YK; Baek, SH; Byun, YS; Cho, KI; Choi, DJ; Choi, SW; Choi, YS; Jang, Y; Jeon, DW; Kim, JY; Kim, KS; Kim, YJ; Lee, SH; Min, PK; Rha, SW | 1 |
| Chi, JF; Guo, HY; Ji, Z; Liu, LB; Lv, HT; Shi, YF; Tang, WL; Xu, FK | 1 |
| Bostan, C; Kaya, A; Ozkan, AA; Uzunhasan, I; Yigit, Z; Yildiz, A | 1 |
1 review(s) available for homocysteine and fluorobenzenes
| Article | Year |
|---|---|
Assay methods for the measurement of total homocyst(e)ine in plasma.
Topics: Bridged Bicyclo Compounds; Chromatography, Gas; Chromatography, High Pressure Liquid; Eating; Electrochemistry; Electrophoresis, Capillary; Fluorescent Dyes; Fluorobenzenes; Fluorometry; Homocysteine; Humans; Hyperhomocysteinemia; Immunoassay; Posture; Reproducibility of Results; Specimen Handling; Spectrometry, Mass, Electrospray Ionization | 2000 |
4 trial(s) available for homocysteine and fluorobenzenes
| Article | Year |
|---|---|
Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia.
Topics: Aged; Arginine; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Endothelium, Vascular; Female; Fluorobenzenes; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Vasodilation | 2004 |
Effect of statins on soluble CD40 ligand in hypercholesterolemic Type 2 diabetic patients.
Topics: Albumins; Biomarkers; Blood Pressure; CD40 Ligand; Diabetes Mellitus, Type 2; Female; Fluorobenzenes; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Interleukin-6; Lipids; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2008 |
Additive effect of homocysteine- and cholesterol-lowering therapy on endothelium-dependent vasodilation in patients with cardiovascular disease.
Topics: Aged; Anticholesteremic Agents; Brachial Artery; Cardiovascular Diseases; Double-Blind Method; Endothelium; Endpoint Determination; Female; Fluorobenzenes; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Male; Middle Aged; Patient Compliance; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Vasodilation; Vitamin B Complex; Vitamins | 2012 |
Non-lipid effects of rosuvastatin-fenofibrate combination therapy in high-risk Asian patients with mixed hyperlipidemia.
Topics: Aged; Asian People; Biomarkers; Blood Glucose; Blood Urea Nitrogen; Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Creatinine; Drug Combinations; Enzymes; Female; Fenofibrate; Fluorobenzenes; Hemoglobins; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Lipids; Liver; Male; Middle Aged; Muscle, Skeletal; Patient Selection; Pyrimidines; Republic of Korea; Rhabdomyolysis; Risk Assessment; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Time Factors; Treatment Outcome | 2012 |
11 other study(ies) available for homocysteine and fluorobenzenes
| Article | Year |
|---|---|
Modification of a high-performance liquid chromatographic method for assay of homocysteine in human plasma.
Topics: Chromatography, High Pressure Liquid; Fluorescent Dyes; Fluorobenzenes; Homocysteine; Humans; Spectrometry, Fluorescence | 1993 |
Assay of plasma homocysteine: light sensitivity of the fluorescent 7-benzo-2-oxa-1, 3-diazole-4-sulfonic acid derivative, and use of appropriate calibrators.
Topics: Calibration; Chromatography, High Pressure Liquid; Cysteine; Drug Stability; Fluorescent Dyes; Fluorobenzenes; Homocysteine; Homocystine; Humans; Light; Quality Control; Reproducibility of Results | 1996 |
Determination of total homocysteine in human plasma by isocratic high-performance liquid chromatography.
Topics: Chromatography, High Pressure Liquid; Cysteine; Fluorescent Dyes; Fluorobenzenes; Homocysteine; Humans; Male; Oxidation-Reduction; Phosphines; Regression Analysis; Reproducibility of Results; Sensitivity and Specificity | 1997 |
Study of factors affecting the determination of total plasma 7-fluorobenzo-2-oxa-1,3-diazole-4-sulfonate (SBD)-thiol derivatives by liquid chromatography.
Topics: Adult; Borohydrides; Chromatography, High Pressure Liquid; Cysteine; Dipeptides; Dithiothreitol; Female; Fluorescent Dyes; Fluorobenzenes; Homocysteine; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Phosphines; Reducing Agents; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Sulfhydryl Reagents | 1998 |
Evaluation and intermethod comparison of the Bio-Rad high-performance liquid chromatographic method for plasma total homocysteine.
Topics: Chromatography, High Pressure Liquid; Fluorescent Dyes; Fluorobenzenes; Homocysteine; Humans; Immunoenzyme Techniques; Oxadiazoles; Reproducibility of Results; Spectrometry, Fluorescence | 1998 |
High-performance liquid chromatographic method for measuring total plasma homocysteine levels.
Topics: Chromatography, High Pressure Liquid; Female; Fluorescent Dyes; Fluorobenzenes; Homocysteine; Humans; Male; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence | 1998 |
Comparison of three different plasma homocysteine assays with gas chromatography-mass spectrometry.
Topics: Fluorescence Polarization Immunoassay; Fluorescent Dyes; Fluorobenzenes; Gas Chromatography-Mass Spectrometry; Homocysteine; Humans; Immunoenzyme Techniques; Reagent Kits, Diagnostic | 1999 |
Total plasma homocysteine analysis by HPLC with SBD-F precolumn derivatization.
Topics: Blood Chemical Analysis; Chromatography, High Pressure Liquid; Fluorescent Dyes; Fluorobenzenes; Homocysteine; Sulfhydryl Reagents | 2000 |
A validated HPLC-fluorescence method with a semi-micro column for routine determination of homocysteine, cysteine and cysteamine, and the relation between the thiol derivatives in normal human plasma.
Topics: Chromatography, High Pressure Liquid; Cysteamine; Cysteine; Fluorobenzenes; Homocysteine; Humans; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence | 2009 |
Effects of rosuvastatin on the production and activation of matrix metalloproteinase-2 and migration of cultured rat vascular smooth muscle cells induced by homocysteine.
Topics: Animals; Atherosclerosis; Cell Movement; Cells, Cultured; Enzyme Activation; Fluorobenzenes; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Matrix Metalloproteinase 2; Myocytes, Smooth Muscle; Pyrimidines; Rats; Rosuvastatin Calcium; Sulfonamides; Tissue Inhibitor of Metalloproteinase-2 | 2013 |
Beneficial effects of rosuvastatin treatment in patients with metabolic syndrome.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Fluorobenzenes; Glycated Hemoglobin; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Lipids; Male; Metabolic Syndrome; Middle Aged; Oxidative Stress; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Time Factors; Treatment Outcome | 2015 |